Sensei Biotherapeutics, Inc. · NASDAQ:SNSE

Ics Opportunities II LLC bought 4,215 and sold 17,076 Sensei Biotherapeutics, Inc. shares (Form 4)

Traded Apr 2 to Apr 7, 2026 · Filed May 15, 2026

From Apr 2 to Apr 7, 2026, Ics Opportunities II LLC (10% owner) bought 4,215 and sold 17,076 Sensei Biotherapeutics, Inc. shares, leaving 133,986 shares. Filed May 15, 2026 (Form 4).

Bought
4,215 shares (US$141K at an average US$33.54)
Sold
17,076 shares (US$538K at an average US$31.51)
Holding after
133,986 shares (held indirectly)
Trading plan
No
Role
10% owner

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Apr 2, 2026Common StockBuy26US$33.47144,974Indirect
Apr 2, 2026Common StockBuy1,276US$34.75144,974Indirect
Apr 2, 2026Common StockBuy701US$35.55144,974Indirect
Apr 2, 2026Common StockSale3,099US$30.86144,974Indirect
Apr 2, 2026Common StockSale1,265US$31.75144,974Indirect
Apr 2, 2026Common StockSale1,794US$32.60144,974Indirect
Apr 2, 2026Common StockSale374US$33.35144,974Indirect
Apr 2, 2026Common StockSale1,134US$34.80144,974Indirect
Apr 6, 2026Common StockBuy1,104US$31.02141,029Indirect
Apr 6, 2026Common StockSale1,214US$31.02141,029Indirect
Apr 6, 2026Common StockSale45US$31.96141,029Indirect
Apr 7, 2026Common StockBuy1,108US$33.38133,986Indirect
Apr 7, 2026Common StockSale2,115US$28.94133,986Indirect
Apr 7, 2026Common StockSale205US$29.71133,986Indirect
Apr 7, 2026Common StockSale4,423US$31.38133,986Indirect
Apr 7, 2026Common StockSale300US$32.25133,986Indirect
Apr 7, 2026Common StockSale1,108US$33.38133,986Indirect

Source

View original at SEC

Related